Stock listing
CHMMF Stock Price, News, Filings & Events — Chimeric Therapeutics Limited
Selected listing: CHMMF · OTC · USD · US
This page tracks Chimeric Therapeutics Limited's CHMMF:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CHMMF:OTC. CHMMF:OTC is the stock-level entry point for investors researching Chimeric Therapeutics Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.

- Ticker
- CHMMF:OTC
- Asset type
- Stock
- Market cap
- $1.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Chimeric Therapeutics Limited CHMMF:OTC stock context
This page tracks Chimeric Therapeutics Limited's CHMMF:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CHMMF:OTC. CHMMF:OTC is the stock-level entry point for investors researching Chimeric Therapeutics Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Chimeric Therapeutics Limited
CHM ceases enrolment in Phase 1 trial and Company update
August 18, 2026
Chimeric receives $1.62M advance on FY26 R&D tax incentive
July 29, 2026
CHM CDH17 Phase 1 clinical trial update - New DL 3 data
July 15, 2026
Appointment of Financial Adviser for Strategic Review
June 30, 2026
CHM announces positive Phase 1/2 data at ASCO
May 31, 2026
Research Chimeric Therapeutics Limited
Chimeric Therapeutics Limited investor report
Review AI stock analysis and investor report context for CHMMF:OTC.
Chimeric Therapeutics Limited company profile
View the public company page for Chimeric Therapeutics Limited on 6ix.
Chimeric Therapeutics Limited news
Read company news and market updates connected to Chimeric Therapeutics Limited.
Chimeric Therapeutics Limited investor events
Find investor webinars, events, and replay context for Chimeric Therapeutics Limited.